



This pamphlet is meant for use by Disease Intervention Specialists and others conducting partner services activities.






























Symptomatic . . . .  60 days before onset of symptoms through date of treatment
Asymptomatic . . .   60 days before date of specimen collection (through date of treatment if patient was not treated  
at time specimen was collected)
Gonorrhea
Symptomatic . . . .  60 days before onset of symptoms through date of treatment
Asymptomatic . . .   60 days before date of specimen collection (through date of treatment if patient was not treated  
at time specimen was collected)
* The time interval for which an index patient is asked to recall sex or drug-injection partners. 
Interview Periods* for Partner Services Programs for Chlamydial Infection, Gonorrhea, Human Immunodeficiency Virus (HIV) Infection  
or Acquired Immunodeficiency Syndrome (AIDS), and Syphilis
Interview  
Periods
HIV infection, AIDS 
 1 or 2 years before date of first positive HIV test through date of interview; might be mitigated  
by evidence of recent infection or availability of verified previous negative test results.  
All current or former spouses during 10 years before diagnosis.
Syphilis†  
Primary Syphilis. . . . . . . . 90 days prior to date of onset of primary lesion** through the date of treatment.
Secondary Syphilis  . . . . . .   6.5 months prior to date of onset of secondary symptoms** through the date of treatment. 
Early Latent Syphilis† . . . . .  1 year prior to start of treatment.
*  The time interval for which an index patient is asked to recall sex or drug-injection partners. Interview periods may be modified if a history of symptoms, a negative test result, or incidental 
treatment are documented. If symptom history is questionable, a maximum interview period should be used. If the patient claims no partners during the interview period, then the most recent 
partner before the interview period should be elicited and notified.
†  Many syphilis cases cannot be staged until after the case is closed. When the stage of syphilis is undetermined at the time of interview, a one-year interview period should be used.
**  If the onset of primary or secondary symptoms is unknown, or questionable, the maximum symptom duration (5 weeks for primary and 6 weeks for secondary) should be used to calculate.  
Interview Periods* for Partner Services Programs for Chlamydial Infection, Gonorrhea, Human Immunodeficiency Virus (HIV) Infection  




I. Introduction  
State	purpose/role		
Assure	confidentiality














   
   
  







































































Begin at the inoculation point of the 
patient suspected of being a spread. 
Make this point the center of the 
partner’s ghosted lesion. The ghosted 
lesion should begin and end 1 ½ weeks 
on either side of the center point to give 
a total 3-week ghosted lesion. 
Ghosting a Spread
Begin at the center of the lesion suspected to be the source of 
infection. Equate this to the inoculation point for the patient 
for whom the spread ghost is being developed. The onset of 
the ghosted lesion should be drawn 3-weeks after the ghosted 
inoculation point, and the ghosted lesion should have a 3-week 
duration. 
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Symptoms of Acute Infection: Symptoms of all types of viral hepatitis are similar, however not 
all newly infected persons show signs of illness.  If symptoms do appear they can include one or 
more of the following: Fever; Fatigue; Loss of appetite; Nausea; Vomiting; Abdominal pain; Gray 
colored bowel movements; Joint pain; and Jaundice.
Hepatitis A Virus (HAV) Infection:
Routes of transmission: Ingestion of fecal matter, even in microscopic amounts, from: Close person-to-
person contact with an infected person; Sexual contact with an infected person; and Ingestion  
of contaminated food or drinks.
Recommended treatment: No medication available. Best addressed through supportive treatment.
Persons at risk: Household members, sex contacts, or caregivers of infected persons; Men who have sex 
with men; Users of certain illegal drugs (injection and non-injection); Persons with clotting-factor 
disorders; and Travelers to regions where HAV is common.




Hepatitis B Virus (HBV) Infection:
Routes of transmission: Contact with infectious blood, semen, and other body fluids, such as through:  
Birth from an infected mother; Sexual contact with an infected person; Sharing of contaminated needles,  
syringes or other injection drug equipment; and Needlesticks or other sharp instrument injuries.
Recommended treatment:  
Acute: No medication available; best addressed through supportive treatment.
Chronic: Regular monitoring for signs of liver disease progression; some patients are treated with antiviral drugs 
Persons at risk: Sex partners of infected persons; Persons with multiple sex partners; Persons with a sexually 
transmitted disease; Men who have sex with men; Injection drug users; Household contacts of infected person
Healthcare and public safety workers exposed to blood on the job; Hemodialysis patients; Residents and staff 
facilities for developmentally disabled persons;  and Travelers to regions with HBsAg prevalence of ≥2%; and 
Infants born to infected mothers.
Prevention: Vaccination for at-risk individuals including MSM, IDU, high-risk heterosexuals (HRHs),  
STD patients, incarcerated persons, and adults with diabetes aged 19 - 59; people aged > 60 years at the  





Hepatitis C Virus (HCV) Infection:
Routes of transmission: Contact with blood of an infected person, primarily through: Sharing of 
contaminated needles, syringes, or other injection drug equipment. Less commonly through:  
sexual contact; birth from an infected mother; and needlestick or other sharp instrument injuries.
Recommended treatment:  
Acute: Antivirals and supportive treatment.  
Chronic: Regular monitoring for signs of liver disease progression; some patients are treated with 
antiviral drugs. New treatments are now available.
Persons at risk: Current or former injection drug users; Recipients of clotting factor concentrates before 
1987; Recipients of blood transfusions or donated organs before July 1992; Long-term hemodialysis 
patients; Persons with known exposures to HCV (e.g., healthcare workers after needlesticks, recipients  
of blood or organs from donor who later tested positive for HCV); HIV-infected persons; and children 
born to infected mothers (do not test before age 18 mos.); and adults born 1945-1965. 




Tuberculosis (TB) is a disease caused by germs that are spread from person to person through the air.  It usually affects 
the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine.  Persons with 
TB can die if they do not get treatment. TB is spread when a person with TB disease of the lungs or throat coughs, 
sneezes, speaks, or sings. These germs can stay in the air for several hours, depending on the environment. 
Persons with active TB disease are considered infectious and may spread TB bacteria to others. 







Recommended treatment: Must be treated with several drugs for 6 to 12 months.
Tuberculosis









Recommended treatment:  Several treatment options are now available to treat latent TB infection and prevent  





Adolescent and Adult Women: Most are asymptomatic, may have abnormal vaginal discharge, pain 
or bleeding during intercourse, bleeding between menstrual periods, pain or burning sensation when 
urinating, urinary frequency, rectal pain or discharge, lower abdominal pain, lower back pain, nausea, or 
fever. 
Adolescent and Adult Men: Most are asymptomatic, may have urethritis, urethral discharge, pain or 
burning sensation when urinating, or rectal pain or discharge. 
Recommended Treatment Regimens
Adolescents and Adults: Azithromycin 1g orally in a single dose OR doxycycline 100 mg orally twice daily 
for 7 days.
Pregnancy: Azithromycin 1 g orally in a single dose OR amoxicillin 500 mg orally 3 times a day for 7 days.
HIV Infection: Patients who have chlamydial infection and also are infected with HIV should receive the 
same treatment as those who are HIV negative.
See STD Treatment Guidelines for Chlamydial Infections Among Infants and Children. 
Gonorrhea
Signs and Symptoms
Adolescent and Adult Men: A burning sensation when urinating, or a white, yellow, or green discharge from the penis, or 
painful or swollen testicles. Rectal discharge, anal itching, soreness, bleeding, or painful bowel soreness and bleeding; most 
pharyngeal infections are asymptomatic.
Adolescent and Adult Women: A painful or burning sensation when urinating, increased vaginal discharge, or vaginal bleeding 
between periods, rectal discharge, anal itching, soreness, bleeding, or painful bowel soreness and bleeding; most pharyngeal 
infections are asymptomatic.
Recommended Treatment Regimens: 
Uncomplicated Infections of the Cervix, Urethra & Rectum: Ceftriaxone 250 mg IM in a single dose OR, IF NOT AN OPTION 
cefixime 400 mg orally in a single dose PLUS azithromycin 1 g orally in a single dose OR doxycycline 100 mg twice daily for 
7 days.* 
Uncomplicated  Infections of the Pharynx: Ceftriaxone 250 mg IM in a single dose PLUS azithromycin 1 g orally in a single dose 
OR doxycycline 100 mg orally twice daily* for 7 days, PLUS Test-of-cure in 1 week.
Pregnancy: As with other patients, pregnant women who have gonococcal infection should be treated with a recommended 
or alternative cephalosporin.  Because spectinomycin is not available in the US, azithromycin 2 g orally can be considered 
for women who cannot tolerate a cephalosporin.  Either amoxicillin or azithromycin is recommended for treatment of 
presumptive or diagnosed chlamydia. 
* Because of the high prevalence of tetracycline resistance among Gonococcal Isolate Surveillance Project isolates, particularly those with elevated minimum inhibitory concentrations to cefixime, the use 
of azithromycin as the second antimicrobial is preferred. 
Gonorrhea
Recommended Treatment Regimens (continued)
HIV Infection: Patients who have gonococcal infection and also are infected with HIV should receive the 
same treatment regimen as those who are HIV negative.
Dual Therapy for Gonococcal and Chlamydial Infections: Patients who have gonococcal infection frequently 
are coinfected with C. trachomatis; it is recommended that patients treated for gonococcal infection also 
be treated routinely with a regimen effective against uncomplicated genital chlamydial infection.
Disseminated Gonococcal Infection (DGI):  
Signs and symptoms: Petechial or pustular acral skin lesions, asymmetrical arthralgia, tenosynovitis, 
or septic arthritis.  
Recommended treatment:  Ceftriaxone 1 g IM or IV every 24 hours.




Stage   Signs and Symptoms
Primary   A single sore (called a chancre) or multiple sores can appear. The chancre is 
usually a firm, round, small, and painless ulcer or chancre at the infection site.
Secondary   Rash on one or more areas of the body can appear.  The rash may appear as 
rough, red, or reddish brown spots both on the palms of the hands and the 
bottoms of the feet.  Fever, swollen lymph glands, sore throat, patchy hair loss, 
headaches, weight loss, muscle aches, and fatigue are other symptoms.
Latent   None.  A positive serologic test for syphilis is the only evidence of infection 
during latent syphilis. Early latent is syphilis infection of less than one year.  
Late latent is syphilis infection of one year or longer. 
Tertiary  Asymptomatic, cardiovascular manifestations, or gummatous lesions.
Neurosyphilis   Cognitive dysfunction, motor or sensory deficits, ophthalmic or auditory 
symptoms, cranial nerve palsies, and symptoms or signs of meningitis. 
Syphilis
Recommended Treatment Regimens 
Primary, Secondary, and Early Latent: Benzathine penicillin G 2.4 million units IM in a single dose.
Late Latent or Unknown Duration: Benzathine penicillin G 7.2 million units total, administered as 3 
doses of 2.4 million units IM each at 1-week intervals. 
Tertiary: Benzathine penicillin G 7.2 million units total, administered as 3 doses of 2.4 million units 
IM each at 1-week intervals. 
Neurosyphilis: Aqueous crystalline penicillin G 18-24 million units per day, administered as 3-4 
million units IV every 4 hours or continuous infusion, for 10-14 days.
Pregnancy: Pregnant women should be treated with the penicillin regimen appropriate for their stage 
of infection.
HIV Infection: HIV infected persons with syphilis should be treated according to the stage-specific 
recommendations for HIV-negative persons. 
See STD Treatment Guidelines for Recommended Syphilis Regimens for Infants and Children. 
Syphilis (continued)
Syphilis
Human Immunodeficiency Virus (HIV)
HIV is the human immunodeficiency virus. It is the virus that can lead to acquired immune deficiency 
syndrome, or AIDS. 
HIV is transmitted from an infected person via unprotected sexual contact, the sharing of needles, 
syringes, or works; from mother to child during the birth process, or through breast feeding; 
transfusion of blood or blood products; and the transplantation of tissues and organs.  Blood (or 
secretions and tissues contaminated by blood) is the major means of transmission.  
Signs and Symptoms
Within a few weeks of being infected with HIV, some people develop fever, fatigue, and generalized 
body rash.  Other signs and symptoms include headache, swollen lymph glands, sore throat, feeling 
achy, nausea, vomiting, diarrhea and night sweats. 
Treatment
A variety of drug combinations may be used and will vary by medical care center.  
HIV
Recommended 
Screening for  
HIV + Patients
Recommended screenings  for HIV + Patients*
Screen for:  
1. Hepatitis B, C  
2. Tuberculosis  
3. Chlamydia†, gonorrhea†, and syphilis
4.  Screen for pregnancy, cervical cancer screening (Pap test) and 
trichomoniasis in females
Vaccinate against:  
1. HBV and HAV
*Please review IDSA HIV Primary Care Guidelines for additional information.  
† Including rectal and/or pharyngeal screening when appropriate
 








































































Below are some examples of currently used social networking 
sites, shopping sites, professional networking sites, microblogs, 
to use as a resource when conducting internet investigations. 
Social networking sites and names may change over time. 
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Referrals
Name of Facility Phone Number
Hepatitis    
Child Protective Services  
Domestic Violence   
Drug/Alcohol Treatment  
Family Counseling   
Family Planning Clinics  
HIV Testing Sites   
Immunization   
Language Assistance   
Maternal and Child Health  
Mental Health   
Prenatal Clinics   
Rape Crisis Center   
STD Clinics   
Temporary Housing   
Tuberculosis Clinics   
Community- Based Organizations 
Referrals

For additional information:   www.cdc.gov/nchhstp
    www.stdhivpreventiontraining.org
    www.cdc.gov/std/training
    www.cdc.gov/std/treatment/2010/default.htm
    www.cdc.gov/hepatitis
    www.knowhepatitis.org
    www.cid.oxfordjournals.org/content/49/5/651.full.pdf+html
For more information on the PSP Quick Guide:
Division of STD Prevention
Program Development and Quality Improvement Branch
404-639-8360
STDTraining@cdc.gov
CS241981
